BPG is committed to discovery and dissemination of knowledge
Articles in Press
11/17/2025 9:17:08 AM | Browse: 57 | Download: 0
Publication Name World Journal of Gastrointestinal Pharmacology and Therapeutics
Manuscript ID 111082
Country China
Category Endocrinology & Metabolism
Manuscript Type Minireviews
Article Title Intestinal-related substances in obesity regulation: A comprehensive review
Manuscript Source Invited Manuscript
All Author List Shuai-Yan Wang, Meng-Zhe Zhang, Zi-Ming Chen, Zi-Mu Li, Cong-Yi Xie, Guan-Hu Yang, Bin Xu and Tian-Cheng Xu
Funding Agency and Grant Number
Funding Agency Grant Number
the National Natural Science Foundation, Youth Science Fund Project 82305376
the Youth Talent Support Project of the China Acupuncture and Moxibustion Association 2024-2026ZGZJXH-QNRC005
the 2024 Jiangsu Province Youth Science and Technology Talent Support Project JSTJ-2024-380
2025 Jiangsu Provincial Science and Technology Think Tank Program Project JSKX0125035
Corresponding Author Tian-Cheng Xu, Key Laboratory of Acupuncture and Medicine Research of Ministry of Education, Nanjing University of Chinese Medicine, No. 138 Xianlin Avenue, Qixia District, Nanjing 210023, Jiangsu Province, China. xtc@njucm.edu.cn
Key Words Obesity; Gut hormones; Microbial metabolites; Indole-3-propionic acid; Gut-brain axis
Core Tip Gut hormones, microbial metabolites, and neurotransmitters such as 5-hydroxytryptamine (serotonin), short-chain fatty acids, and indolepropionic acid play crucial roles in regulating metabolism and obesity. Emerging therapies like glucagon-like peptide-1 receptor agonists and gut microbiota modulation show promise in addressing these factors. Future research should focus on personalized, multi-target approaches for effective obesity management, optimizing treatments, and understanding the diverse impacts of gut-derived substances on metabolic healt
Citation Wang SY, Zhang MZ, Chen ZM, Li ZM, Xie CY, Yang GH, Xu B, Xu TC. Intestinal-related substances in obesity regulation: A comprehensive review. World J Gastrointest Pharmacol Ther 2025; In press
Received
2025-06-23 09:52
Peer-Review Started
2025-06-23 09:54
To Make the First Decision
Return for Revision
2025-08-07 01:24
Revised
2025-08-20 16:55
Second Decision
2025-11-17 02:44
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief
2025-11-17 09:17
Articles in Press
2025-11-17 09:17
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 2150-5349 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com